These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25552257)
1. Procyanidin B2 3,3″-di-O-gallate inhibits endothelial cells growth and motility by targeting VEGFR2 and integrin signaling pathways. Kumar R; Deep G; Wempe MF; Agarwal R; Agarwal C Curr Cancer Drug Targets; 2015; 15(1):14-26. PubMed ID: 25552257 [TBL] [Abstract][Full Text] [Related]
2. Differential effect of grape seed extract and its active constituent procyanidin B2 3,3″-di-O-gallate against prostate cancer stem cells. Tyagi A; Kumar S; Raina K; Wempe MF; Maroni PD; Agarwal R; Agarwal C Mol Carcinog; 2019 Jul; 58(7):1105-1117. PubMed ID: 30828884 [TBL] [Abstract][Full Text] [Related]
3. Procyanidin B2 3,3″-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK. Kumar R; Deep G; Wempe MF; Surek J; Kumar A; Agarwal R; Agarwal C Mol Carcinog; 2018 Jan; 57(1):57-69. PubMed ID: 28876465 [TBL] [Abstract][Full Text] [Related]
4. Procyanidin B2 3,3(″)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-κB, Stat3, and AP1 transcription factors. Tyagi A; Raina K; Shrestha SP; Miller B; Thompson JA; Wempe MF; Agarwal R; Agarwal C Nutr Cancer; 2014; 66(4):736-46. PubMed ID: 24191894 [TBL] [Abstract][Full Text] [Related]
5. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention. Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440 [TBL] [Abstract][Full Text] [Related]
6. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437 [TBL] [Abstract][Full Text] [Related]
7. Diversity in human placental microvascular endothelial cells and macrovascular endothelial cells. Huang X; Jia L; Qian Z; Jia Y; Chen X; Xu X; Chang X; Liu M; Wang K Cytokine; 2018 Nov; 111():287-294. PubMed ID: 30269024 [TBL] [Abstract][Full Text] [Related]
8. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway. Niu G; Sun L; Pei Y; Wang D Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844 [TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
10. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Yi T; Yi Z; Cho SG; Luo J; Pandey MK; Aggarwal BB; Liu M Cancer Res; 2008 Mar; 68(6):1843-50. PubMed ID: 18339865 [TBL] [Abstract][Full Text] [Related]
11. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling. Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031 [TBL] [Abstract][Full Text] [Related]
12. Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling. Jin S; Yun HJ; Jeong HY; Oh YN; Park HJ; Yun SG; Kim BW; Kwon HJ Oncol Rep; 2015 Sep; 34(3):1178-84. PubMed ID: 26133679 [TBL] [Abstract][Full Text] [Related]
13. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways. Li X; Wang X; Ye H; Peng A; Chen L Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678 [TBL] [Abstract][Full Text] [Related]
14. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling. Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875 [TBL] [Abstract][Full Text] [Related]
15. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs. Chuang IC; Yang CM; Song TY; Yang NC; Hu ML Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173 [TBL] [Abstract][Full Text] [Related]
16. Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway. Wang Q; Liu J; Guo T; Liu D; Pan J Med Sci Monit; 2019 Jan; 25():700-710. PubMed ID: 30675875 [TBL] [Abstract][Full Text] [Related]
17. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway. Jiang JH; Pi J; Cai JY Pathol Res Pract; 2020 Aug; 216(8):153031. PubMed ID: 32703495 [TBL] [Abstract][Full Text] [Related]
18. Marsdeniae tenacissimae extract (MTE) suppresses cell proliferation by attenuating VEGF/VEGFR2 interactions and promotes apoptosis through regulating PKC pathway in human umbilical vein endothelial cells. Chen BY; Chen D; Lyu JX; Li KQ; Jiang MM; Zeng JJ; He XJ; Hao K; Tao HQ; Mou XZ; Ying YM; Zhang W; Zhu MH; Wang Z Chin J Nat Med; 2016 Dec; 14(12):922-930. PubMed ID: 28262119 [TBL] [Abstract][Full Text] [Related]
19. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. Huang SW; Lien JC; Kuo SC; Huang TF Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319 [TBL] [Abstract][Full Text] [Related]
20. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis. Zhu GS; Tang LY; Lv DL; Jiang M Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]